Marc Philouze has international experience as a company executive, private equity investor, and more recently as an industry business advisor. Mr. Philouze is mainly focused on the consumer sector with a broad knowledge of the B2B ingredient sector for segments such as Food, Nutrition and Cosmetics. He is currently the Principal at AdviBio, LLC, a consulting boutique focused on providing advisory services to innovative companies in the consumer industries.

Mr. Philouze is the former CEO and President of DianaPlantSciences, a US-based innovator in the sustainable production of bioactive ingredients via plant cell culture. He also managed US operations for the Food Division of the Diana Group, a leader in providing “Performance from Nature” solutions to its clients in the Food & Beverage ingredient sector. Prior to Diana, from 2007 to 2010, Mr. Philouze was a private equity investor with Apax Partners in Europe, focusing on growth equity and leveraged buy-out investments in mid-market life sciences and healthcare companies. Earlier in his career, Mr. Philouze held management roles at Pfizer and then Gilead Sciences.

Mr. Philouze earned an MSc in Engineering from Ecole Centrale Paris, a top-3 engineering university in France, and an MSc in International Accounting and Finance from the London School of Economics. He received his MBA from Harvard Business School.